Inspire Medical Systems Prepares for Significant Conference Presentation
Inspire Medical Systems, Inc. (NYSE: INSP), a pioneering medical technology organization dedicated to providing advanced solutions for patients suffering from obstructive sleep apnea, has announced its participation in a noteworthy event. The UBS Global Healthcare Conference will feature a presentation by Inspire’s management team on a date yet to be confirmed.
Overview of the Conference
The presentation is set to occur at 11:00 a.m. Eastern Time. As part of this significant engagement, attendees will have the opportunity to view the presentation through a live webcast, facilitating broader access to Inspire's insights and innovations.
Accessible Replays
For those unable to attend the live session, Inspire also plans to offer a replay of the presentation. Webcast replays will be accessible for two weeks following the event, ensuring that both investors and interested parties can review the key highlights and discussions at their convenience.
Understanding Inspire Medical Systems
Inspire is committed to the research and development of minimally invasive treatments for obstructive sleep apnea, a condition that affects millions worldwide. Their flagship product, the Inspire therapy, stands out as a groundbreaking solution. Notably, it is the only neurostimulation technology of its nature approved by the FDA, EU MDR, and PDMA, marking a milestone in the treatment landscape.
Impact of Inspire Therapy
This innovative therapy is designed to offer patients a safer and more effective option for managing moderate to severe sleep apnea. By incorporating advanced neurostimulation technology, Inspire provides an alternative to traditional continuous positive airway pressure (CPAP) systems, which are often faced with compliance challenges among users.
The Journey Ahead
As Inspire Medical Systems continues to expand its reach and encourage dialogue within the healthcare community, its presentations at conferences like UBS serve as a vital platform. These engagements not only illustrate the company's advancements but also enhance awareness regarding sleep apnea and the potential of neurostimulation therapies.
Investor and Media Relations
Inspire Medical Systems encourages stakeholders to stay connected for further updates. Ezgi Yagci, the Vice President of Investor Relations, is available for inquiries, allowing for a direct line of communication. Interested parties can reach out via phone or email, reinforcing Inspire’s commitment to transparency and engagement with the investing public.
Contact Information
For immediate assistance, Ezgi Yagci can be contacted at 617-549-2443 or through email at ezgiyagci@inspiresleep.com. This open channel exemplifies Inspire Medical Systems' dedication to maintaining strong relationships with investors and the media.
Frequently Asked Questions
What is the main focus of Inspire Medical Systems?
Inspire Medical Systems focuses on developing and commercializing innovative, minimally invasive solutions for obstructive sleep apnea.
When is Inspire's presentation at the UBS Global Healthcare Conference?
The presentation is scheduled for 11:00 a.m. Eastern Time, with the exact date to be confirmed.
How can I access the presentation if I can't attend live?
Individuals can access a replay of the presentation available for two weeks following the event on Inspire’s Investor website.
What makes Inspire therapy unique?
Inspire therapy is the first neurostimulation technology of its kind to receive FDA, EU MDR, and PDMA approval, offering an effective treatment for those with obstructive sleep apnea.
What contact resources does Inspire provide for investor inquiries?
Inspire Medical Systems provides contact details for their Vice President of Investor Relations, Ezgi Yagci, available by phone and email for inquiries.
